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 Ideally, drugs are applied in vivo at exactly the therapeutic concentration and precisely 
target the cells that cause disease. However, drug delivery is not easily controlled. 
 
Tibbitt et al. (2016) J. Am. Chem. Soc. 138 (3): 704−717. 
 
 Sample preparation is the most critical step in fluorescence microscopy experiments, as 
is clear from the microscopists’ motto ‘garbage in = garbage out’. 
 
Jonkman et al. (2020) Nat. Protoc. 15 (5): 1585−1611. 
 
 The usefulness of a blood-brain barrier model is not absolute, but depends on its 
representational capacity of the selected aspect that is under study. 
 
Naik and Cucullo (2012) J. Pharm. Sci. 101 (4): 1337−1354. 
 
 After its endocytosis a molecule is still topologically “outside” the cell, as it is contained 
in a vesicle, i.e. it is separated from the cell interior by a membrane. 
 
Deprey et al. (2019) Bioconjug. Chem. 30 (4): 1006−1027. 
 
 Without an effort in the development of drug delivery systems capable of traversing the 
blood-brain barrier that is equal to the effort in drug discovery for brain diseases, the 
current disappointing FDA approval rate of medications to treat brain diseases is not 
expected to change. 
 
Pardridge (2020) Front. Aging Neurosci. 11: 373. 
 
 If you want to go fast, go alone. If you want to go far, go together. 
 
African proverb. 
